ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 306107 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 306107; 2) Community: the network communities that were significantly associated with the response to NSC 306107; 3) Molecule: the relationships between components within communities and NSC 306107; 4) MDR: the compounds that were significantly associated with the NSC 306107.

NSC Compound Enrichment Correlation
NSC 762346 Null 0.0352028253287042 -0.039532937
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0352028253287042 0.12540267
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0352028253287042 0.085429296
NSC 81280 Null 0.0352028253287042 0.50558979
NSC 335791 3-Azabicyclo[3.2.2]nonane-3-carbothioic acid, [1-(2-pyridinyl)butylidene]hydrazide 0.036145517892443 0.14615069
NSC 372474 Null 0.036145517892443 -0.29787689
NSC 622700 Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide 0.036145517892443 -0.23353155
NSC 695323 Null 0.036145517892443 -0.16262149
NSC 728323 16-[3-Methoxy-4-(2-pyrrolidine-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.036145517892443 -0.10024698
NSC 100046 Elephantopin 0.0376362543535812 -0.12974452
Total:120  Current:90    [First] [Prev] [Next] [Last]